Rare Diseases Symptoms Automatic Extraction
Home
A random Abstract
Our Project
Our Team
Expression of aspartoacylase (ASPA) and Canavan disease.
[canavan disease]
Canavan
disease
(
CD
)
is
a
neurodegenerative
disorder
usually
presenting
in
the
first
six
months
of
life
.
CD
patients
can
be
identified
via
elevated
levels
of
N-
acetyl-l-aspartate
in
the
pattern
of
urinary
organic
acids
assessed
by
gas
chromatography-mass
spectrometry
.
They
are
characterized
by
deficiency
of
aspartoacylase
(
aminoacylase
2
;
ASPA
)
due
to
mutations
in
the
ASPA
gene
.
Information
on
the
molecular
basis
of
CD
is
rather
sparse
.
A
lack
of
expression
studies
of
ASPA
mutant
proteins
in
appropriate
expression
systems
has
prompted
this
investigation
.
Studies
with
overexpressed
ASPA
mutant
proteins
were
carried
out
in
the
HEK
293
cell
line
,
which
provides
the
authentic
human
machinery
for
posttranslational
modifications
.
All
ASPA
mutants
tested
(
ASPA
Arg
168
H
is
,
ASPA
Pro
181
Thr
,
ASPA
Tyr
288
Cys
,
ASPA
Phe
295
S
er
,
and
ASPA
Ala
305
G
lu
)
showed
loss
of
ASPA
activity
,
which
can
be
explained
by
the
intramolecular
effects
of
the
mutations
in
the
enzyme
.
The
mutation
p
.
Phe
295
Ser
even
leads
to
absent
ASPA
mRNA
expression
,
as
revealed
by
quantitative
real-time
PCR
.
Using
this
approach
,
ASPA
gene
expression
analysis
yielded
high
levels
of
human
ASPA
gene
expression
not
only
in
brain
and
kidney
,
but
also
in
lung
and
liver
.
More
information
of
ASPA
localization
in
human
organs
and
detailed
characterization
of
mutations
leading
to
a
deficiency
of
ASPA
can
contribute
to
a
better
understanding
of
this
inborn
error
of
metabolism
.
Diseases
Validation
Diseases presenting
"high levels"
symptom
22q11.2 deletion syndrome
adrenal incidentaloma
allergic bronchopulmonary aspergillosis
alpha-thalassemia
aromatase deficiency
cadasil
canavan disease
classical phenylketonuria
congenital adrenal hyperplasia
congenital toxoplasmosis
cutaneous mastocytosis
cystinuria
dentin dysplasia
dentinogenesis imperfecta
dracunculiasis
dystrophic epidermolysis bullosa
erythropoietic protoporphyria
gm1 gangliosidosis
hereditary cerebral hemorrhage with amyloidosis
holt-oram syndrome
homocystinuria without methylmalonic aciduria
kabuki syndrome
kallmann syndrome
liposarcoma
papillon-lefèvre syndrome
phenylketonuria
primary effusion lymphoma
primary hyperoxaluria type 1
scrub typhus
severe combined immunodeficiency
systemic capillary leak syndrome
triple a syndrome
von hippel-lindau disease
werner syndrome
wiskott-aldrich syndrome
wolf-hirschhorn syndrome
x-linked adrenoleukodystrophy
zellweger syndrome
You can validate or delete this automatically detected symptom
Validate the Symptom
Delete the Symptom